Striking the right balance between value and price in pharmaceuticals

SDA Bocconi Insight - Zoom On - C. Jommi


Last summer, Decree 9 of August 2019 was published in the Official Gazette, which revised the system for regulating drug pricing in Italy (Price Decree). The Italian Drug Agency (AIFA) held a public consultation, which wrapped up in September, to discuss guidelines consequent to the new legislative initiative during which drug companies submitted documentation to substantiate requests on eligibility for reimbursement and prices of their products. CERGAS (the Italian Research Center for Healthcare Management) at SDA Bocconi School of Management participated in this public consultation with a document in which, in addition to offering certain technical observations, underscored the importance of making decisions based on a structured and reproducible assessment of the value of new pharmaceuticals.



Related News

11 May 2021
An inventor and a manager, an (almost) ...
An inventor and a manager, an (almost) foregone success story
MIHMEP Alumnus among Forbes 100 most influential young people
Learn More
14 December 2020
A Go to Market Approach to Healthcare
A Go to Market Approach to Healthcare
Learn More
01 December 2020
OASI Report: 21 February, 2020, the Day That ...
OASI Report: 21 February, 2020, the Day That Changed the Italian Healthcare System
Learn More

Related Programs

HOSPITAL MANAGEMENT the simulation & the pandemic
  • Start date
  • Duration
  • Format
  • Language
  • 1 dec 2021
  • 3,5 days
  • online
  • English

A realistic exercise that effectively simulates the complexity and intensity of the evolving healthcare environment especially during times of crisis.

Healthcare programs
  • Language
  • Italian

SDA Bocconi aims to train professionals with skills, passion, and talent to serve institutions and companies operating in the health and social care systems, in order to meet the current challenges and their future development.